Shenzhen Jinwan Biotechnology Co., Ltd – Trademark Portfolio

Entity Type: 99

Shenzhen Jinwan Biotechnology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include UARCOOL. The owner is based in Longhua Dist, Shenzhen.

Gonghe New Village, Songhe, Longhua St.,

1107, No. 3, Lane 2, Guoqin District,

Longhua Dist, Shenzhen 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

UARCOOL
UARCOOL
Registered 2024

Trademark Classifications

Shenzhen Jinwan Biotechnology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Shenzhen Jinwan Biotechnology Co., Ltd have?

Shenzhen Jinwan Biotechnology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Jinwan Biotechnology Co., Ltd file in?

Shenzhen Jinwan Biotechnology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Shenzhen Jinwan Biotechnology Co., Ltd's most well-known trademarks?

Shenzhen Jinwan Biotechnology Co., Ltd's registered trademark portfolio includes well-known marks such as UARCOOL. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Jinwan Biotechnology Co., Ltd's trademark registration success rate?

Shenzhen Jinwan Biotechnology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.